CHICAGO — In this Healio Video Perspective from the AAO meeting, Mitchell C. Shultz, MD, discusses a study that compared the iStent inject W and Hydrus microstent to treat glaucoma in patients who have and have not undergone canaloplasty.
“While both stents are working extremely well for patients, we do have a slightly higher adverse events incidence in the patients with Hydrus stents,” he said.